North America Embolotherapy Market Forecast to 2028 – COVID

North America Embolotherapy Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Embolic Agent and Support Device), Disease Indication (Cancer, Peripheral Vascular Disease, Neurological Disease, Urological and Nephrological Disorder, Gastrointestinal Disorder, and Other), Procedure [Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT), and Transarterial Chemoembolization (TACE)], and End User (Hospital & Clinic, Ambulatory Surgery Center, and Other End User)

Report Code : BMIRE00027551 | Region : North America | Industry : Medical Device | Published Date : 24/Nov/2022

The embolotherapy market in North America is expected to grow from US$ 1,354.02 million in 2022 to US$ 2,245.73 million by 2028. It is estimated to grow at a CAGR of 8.8% from 2022 to 2028.

Rising Preference for Minimally Invasive Procedures Drives Growth of Embolotherapy Market in North America Patients increasingly prefer minimally invasive surgeries due to their various advantages such as low postoperative pain, less postoperative complications, short hospital stays, and fast recovery times. Trans Arterial Chemo Embolization (TACE) is a minimally invasive procedure that is typically used to treat hepatocellular carcinoma. TACE is used for patients suffering from asymptomatic and unresectable liver cancer. TACE can be used to diminish the size of the tumor and make the patient eligible for liver transplantation. It is considered an evolution from a formerly applied technique called Trans-catheter Arterial Embolization (TAE). Bleeding is a common issue in cancer patients, related to local tumor invasion, tumor angiogenesis, systemic effects of cancer, and anti-cancer treatments. TACE involves a two-step process—selective arterial occlusion restricts the blood supply to the tumor, which causes ischemic tumor necrosis, and regional chemotherapy helps the drug remain in the area for a prolonged period, which starts causing the therapeutic effects. Prostatic artery embolization (PAE) is also a minimally invasive therapy implemented as an elective outpatient technique for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). The number of patients treated with PAE has grown in recent years. Thus, the increasing preference for minimally invasive procedures is fueling the embolotherapy market growth in North America.

Market Overview

The North America embolotherapy market is segmented into the US, Canada, and Mexico. The US held the largest share of the market in 2021, owing to the growing prevalence of hepatocellular cancer and liver cancer coupled with the increasing focus of the major manufacturers on technological advancements. Furthermore, the advanced healthcare sector of the region, the prevalence of sophisticated technological healthcare facilities. The embolotherapy market in the region is anticipated to grow significantly in the coming years owing to the rising cases of brain aneurysms. According to the Brain Aneurysm Foundation’s report, ~6 million people have unruptured brain aneurysms in the US. Also, the annual rate of rupture is nearly 8–10 per 100,000 people; ~30,000 people in the country suffer from a brain aneurysm rupture. In addition, about 4 out of 7 people who recover from a ruptured brain aneurysm are likely to suffer from the disabilities. This neurological disorder generally affects people who are in the age group of 35–60 years. However, the brain aneurysm can also be seen in children, and women in the country suffer more than men.

North America Embolotherapy Market Revenue and Forecast to 2028 (US$ Million)

North America Embolotherapy Market Segmentation

The North America embolotherapy market is segmented on the basis of product, disease indication, procedure, end user, and country.

Based on product, the North America embolotherapy market is bifurcated into embolic agents and support devices. The embolic agents segment held a larger market share in 2022. Based on disease indication, the North America embolotherapy market is segmented into cancer, neurological diseases, urological and nephrological disorders, peripheral vascular diseases, gastrointestinal disorders, and others. The cancer segment held the largest market share in 2022. Based on procedure, the North America embolotherapy market is segmented into transcatheter arterial embolization (TAE), transcatheter arterial radioembolization/selective internal radiation therapy, and transarterial chemoembolization (TACE). The transcatheter arterial embolization (TAE) segment held the largest market share in 2022. Based on end user, the North America embolotherapy market is segmented into hospitals and clinics, ambulatory surgical centers, and other end users. The hospitals and clinics segment held the largest market share in 2022. Based on country, the North America embolotherapy market is segmented into the US, Canada, and Mexico. The US dominated the market in 2022. Abbott Laboratories, Boston Scientific Corporation, Cook Medical LLC, Johnson & Johnson, Medtronic, Acandis GmbH, Balt USA LLC, Stryker Corporation, Guerbet LLC, and Terumo Corporation are among the leading companies operating in the embolotherapy market in North America.

At 8.8% CAGR, the North America Embolotherapy Market is speculated to be worth US$ 2,245.73 million by 2028, says The Insight Partners

According to The Insight Partners’ research, the North America embolotherapy market was valued at US$ 1,354.02 million in 2022 and is expected to reach US$ 2,245.73 million by 2028, registering an annual growth rate of 8.8% from 2022 to 2028. Burgeoning incidence of cancer cases and boosting patient preference for minimally invasive procedures.

The five most common types of cancer are breast, prostate, cervical, lung, and colorectal. However, of these five cancers, the leading cause of cancer-related death is lung cancer. Even though breast cancer has at least a 25% higher incidence among women, cervical carcinoma was the leading cause of death in 2020. According to National Cancer Registry (NCR), in 2020, ~110,000 new cases of cancer were diagnosed in South Africa, with over 56,000 cancer-related deaths, representing a quarter of premature noncommunicable disease-related mortality. This significant cancer burden is predicted to increase in the coming decades, with the incidence of new cases of cancer expected to rise to 138,000 and 175,000 by 2030 and 2040, respectively. Cancer-related mortality is predicted to rise to 73,000 and 94,000 during the same period. Moreover, according to the American Cancer Society journal, in 2021, an estimated 1.9 million new cancer cases will be diagnosed and 608,570 cancer deaths in the United States. Embolization is used to stop bleeding or block blood flow to a tumor or abnormal area of tissue. It is also used to treat liver and kidney cancer and neuroendocrine tumors. Embolizing agents, including embolic microspheres (beads), are used to restrict the vascular supply of tumors, and can be loaded with chemotherapeutic medicines, which elute and diffuse into the tissue. The vascular embolization device (previously the arterial embolization device) is intended to control hemorrhaging due to aneurysms, certain types of tumors, and arteriovenous malformations. The pipeline embolization device is used for the treatment of large and giant wide-neck intracranial aneurysms in the internal carotid artery. It helps prevent aneurysms and tumors from growing and causing harm to essential organs. Thus, the rising prevalence of cancer cases is creating a high demand for embolotherapy products.

On the contrary, availability of other alternative therapies.

Based on product, the North America embolotherapy market is segmented into embolic agents and support devices. The embolic agents segment held 84.5% market share in 2022, embolic agents US$ 1,054.36 million. It is projected to garner US$ 1,912.77 million by 2028 to expand at 8.9% CAGR during 2022–2028. Based on Disease Indication, the North America embolotherapy market is categorized into cancer, neurological diseases, urological and nephrological disorders, peripheral vascular diseases, gastrointestinal disorders, and others. The cancer segment held 26.1% market share in 2022, amassing US$ 353.72 million. It is projected to garner US$ 615.05 million by 2028 to expand at 9.7% CAGR during 2022–2028. Based on procedure, the North America embolotherapy market is segmented into transcatheter arterial embolization (TAE), transcatheter arterial radioembolization/selective internal radiation therapy, and transarterial chemoembolization (TACE). The transcatheter arterial embolization segment held 52.6% market share in 2022, amassing US$ 712.33 million. It is projected to garner US$ 1,206.45 million by 2028 to expand at 9.2% CAGR during 2022–2028. Based on end user, the North America embolotherapy market is segmented into hospitals and clinics, ambulatory surgical centers, and other end users. The hospitals and clinics segment held 73.0% market share in 2022, amassing US$ 987.83 million. It is projected to garner US$ 1,648.45 million by 2028 to expand at 8.9% CAGR during 2022–2028. Based on country, the North America embolotherapy market has been segmented into the US, Canada, and Mexico. Our regional analysis states that the US captured 79.8% market share in 2022. It was assessed at US$ 1,080.92 million in 2022 and is likely to hit US$ 1,806.56 million by 2028, exhibiting a CAGR of 8.9% during the forecast period. Key players dominating the North America embolotherapy market are Abbott Laboratories; Boston Scientific Corporation; Cook Medical LLC; Johnson & Johnson; Medtronic; Acandis GmbH; Balt USA LLC; Stryker Corporation; Guerbet LLC; and Terumo Corporation among others.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Embolotherapy Market – by Product

1.3.2 North America Embolotherapy Market – by Disease Indication

1.3.3 North America Embolotherapy Market – by Procedure

1.3.4 North America Embolotherapy Market – by End User

1.3.5 North America Embolotherapy Market– By Country

2. North America Embolotherapy Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Embolotherapy Market Landscape

4.1 Overview

4.2 PEST Analysis

4.3 Expert Opinion

5. North America Embolotherapy Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Burgeoning Incidence of Cancer Cases

5.1.2 Boosting Patient Preference for Minimally Invasive Procedures

5.2 Market Restraints

5.2.1 Availability of Other Alternative Therapies

5.3 Market Opportunity

5.3.1 Elevating Applications of Embolotherapy

5.4 Market Trend

5.4.1 Widening Use of Liquid Embolic Agents

5.5 Impact analysis

6. North America Embolotherapy Market Analysis

6.1 North America Embolotherapy Market Revenue Forecast and Analysis

7. North America Embolotherapy Market – by Product

7.1 Overview

7.2 North America Embolotherapy Market Revenue Share, by Products 2022 & 2028 (%)

7.3 Embolic Agents

7.3.1 Overview

7.3.2 Embolic Agents: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.3 Microspheres

7.3.3.1 Overview

7.3.3.2 Microspheres: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.4 Embolic Coils

7.3.4.1 Overview

7.3.4.2 Embolic Coils: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.5 Embolic Plug Systems

7.3.5.1 Overview

7.3.5.2 Embolic Plug Systems: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.6 Detachable Balloons

7.3.6.1 Overview

7.3.6.2 Detachable Balloons: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.7 Liquid Embolic Agents

7.3.7.1 Overview

7.3.7.2 Liquid Embolic: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.8 Others

7.3.8.1 Overview

7.3.8.2 Others: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.4 Support Devices

7.4.1 Overview

7.4.2 Support Devices: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.4.3 Microcatheters

7.4.3.1 Overview

7.4.3.2 Microcatheters: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.4.4 Guidewires

7.4.4.1 Overview

7.4.4.2 Guidewires: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

8. North America Embolotherapy Market Analysis – by Disease Indication

8.1 Overview

8.2 North America Embolotherapy Market Revenue Share, by Disease Indication 2022 & 2028 (%)

8.3 Cancer

8.3.1 Overview

8.3.2 Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.1 Liver Cancer

8.3.2.1.1 Overview

8.3.2.1.2 Liver Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.2 Kidney Cancer

8.3.2.2.1 Overview

8.3.2.2.2 Kidney Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.3 Other Cancers

8.3.2.3.1 Overview

8.3.2.3.2 Other Cancers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Peripheral Vascular Diseases

8.4.1 Overview

8.4.2 Peripheral Vascular Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Neurological Diseases

8.5.1 Overview

8.5.2 Neurological Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Urological and Nephrological Disorders

8.6.1 Overview

8.6.2 Urological and Nephrological Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Gastrointestinal Disorders

8.7.1 Overview

8.7.2 Gastrointestinal Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.8 Others

8.8.1 Overview

8.8.2 Others: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Embolotherapy Market Analysis – by Procedure

9.1 Overview

9.2 North America Embolotherapy Market Revenue Share, by Procedure 2022 & 2028 (%)

9.3 Transcatheter Arterial Embolization (TAE)

9.3.1 Overview

9.3.2 Transcatheter Arterial Embolization (TAE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT)

9.4.1 Overview

9.4.2 Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Transarterial Chemoembolization (TACE)

9.5.1 Overview

9.5.2 Transarterial Chemoembolization (TACE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

10. North America Embolotherapy Market Analysis – By End User

10.1 Overview

10.2 North America Embolotherapy Market Revenue Share, By End User 2022 & 2028 (%)

10.3 Hospitals and Clinics

10.3.1 Overview

10.3.2 Hospitals: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

10.4 Ambulatory Surgical Centers

10.4.1 Overview

10.4.2 Ambulatory Surgical Centers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

10.5 Other End Users

10.5.1 Overview

10.5.2 Other End Users: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11. North America Embolotherapy Market – Country Analysis

11.1 North America Embolotherapy Market

11.1.1 North America: Embolotherapy Market, by Country, 2022 & 2028 (%)

11.1.1.1 US: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.1 US: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.2 US Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.2.1 US Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.2.2 US Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.3 US Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.3.1 US Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.4 US Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.5 US Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

11.1.1.2 Canada: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.1 Canada: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.2 Canada Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.2.1 Canada Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.2.2 Canada Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.3 Canada Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.3.1 Canada Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.4 Canada Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.5 Canada Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

11.1.1.3 Mexico: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.1 Mexico: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.2 Mexico Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.2.1 Mexico Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.2.2 Mexico Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.3 Mexico Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.3.1 Mexico Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.4 Mexico Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.5 Mexico Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

12. Embolotherapy Market –Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. Company Profiles

13.1 Abbott Laboratories

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Boston Scientific Corporation

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Cook Medical LLC

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Johnson & Johnson

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Medtronic

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Acandis GmbH

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Balt USA LLC

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Stryker Corporation

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Guerbet LLC

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Terumo Corporation

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES.

Table 1. US Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 2. US Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

Table 3. US Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

Table 4. US Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 5. US Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

Table 6. US Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

Table 7. US Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

Table 8. Canada Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)

Table 9. Canada Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)

Table 10. Canada Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)

Table 11. Canada Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)

Table 12. Canada Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)

Table 13. Canada Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)

Table 14. Canada Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)

Table 15. Mexico Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 16. Mexico Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

Table 17. Mexico Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

Table 18. Mexico Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 19. Mexico Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

Table 20. Mexico Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

Table 21. Mexico Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

Table 22. Organic Developments Done by Companies

Table 23. Inorganic Developments Done by Companies

Table 24. Glossary of Terms, North America Embolotherapy Market

LIST OF FIGURES.

Figure 1. North America Embolotherapy Market Segmentation

Figure 2. North America Embolotherapy Market, By Country

Figure 3. North America Embolotherapy Market Overview

Figure 4. Embolic Agents Held Largest Share of Product Segment in Embolotherapy Market

Figure 5. Embolotherapy Market in North America to Show Remarkable Growth During Forecast Period

Figure 6. North America Embolotherapy Market, Industry Landscape

Figure 7. North America PEST Analysis

Figure 8. North America Embolotherapy Market Impact Analysis of Drivers and Restraints

Figure 9. North America Embolotherapy Market– Revenue Forecast and Analysis – 2020- 2028

Figure 10. North America Embolotherapy Market Revenue Share, by Products 2022 & 2028 (%)

Figure 11. Embolic Agents: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 12. Microspheres: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 13. Embolic Coils: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 14. Embolic Plug Systems: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 15. Detachable Balloons: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 16. Liquid Embolic: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 17. Others: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 18. Support Devices: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 19. Microcatheters: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 20. Guidewires: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 21. North America Embolotherapy Market Revenue Share, by Disease Indication 2022 & 2028 (%)

Figure 22. Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. Liver Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. Kidney Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Other Cancers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. Peripheral Vascular Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. Neurological Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28. Urological and Nephrological Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29. Gastrointestinal Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30. Others: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31. North America Embolotherapy Market Revenue Share, by Procedure 2022 & 2028 (%)

Figure 32. Transcatheter Arterial Embolization (TAE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33. Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34. Transarterial Chemoembolization (TACE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35. North America Embolotherapy Market Revenue Share, By End User 2022 & 2028 (%)

Figure 36. Hospitals: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 37. Ambulatory Surgical Centers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 38. Other End Users: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 39. North America: Embolotherapy Market, by Key Country – Revenue (2022) (US$ Million)

Figure 40. North America: Embolotherapy Market, by Country, 2022 & 2028 (%)

Figure 41. US: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 42. Canada: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 43. Mexico: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

The List of Companies - North America Embolotherapy Market

● Abbott Laboratories

● Boston Scientific Corporation

● Cook Medical LLC        

● Johnson & Johnson

● Medtronic

● Acandis GmbH  

● Balt USA LLC

● Stryker Corporation

● Guerbet LLC

● Terumo Corporation

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America embolotherapy market.

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the North America embolotherapy market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth North America market trends and outlook coupled with the factors driving the embolotherapy market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

TOP